Aquis Rule 4.14
National Milk Records plc is a publicly listed business trading on the Aquis Stock Exchange growth market.
Gowling WLG (UK) LLP
4 More London Riverside
Canaccord Genuity Limited
88 Wood Street
PO Box 4630
Corporate Public Relations
4-5 Castle Court
The company is incorporated in England and Wales with registered company number 03331929. The main country of operations is the United Kingdom and falls under the auspices of the companies act 2006.
Following the change of ownership of NEX Exchange in July 2019, and in order to comply with the new rules of the exchange, the Directors elected to adopt the Quoted Companies Alliance Corporate Governance Code (‘the QCA code’) insofar as appropriate in relation to the nature and size of the company. We believe that the Company already adopts most of the principles of the QCA code, and we are working with our Corporate Advisors to assure and better articulate our compliance.
NMR is the leading supplier of essential management information to the UK dairy supply chain. Through a team of self-employed milk-recorders, it collects and tests milk samples for approximately 50% of the UK's two million cows. In addition, its laboratories provide payment testing and disease testing services for Britain's milk processors. NMR has a joint-venture laboratory in the Republic of Ireland providing similar services to farmers and processors across the whole of Ireland. Another division of the Group is a livestock traceability business, Nordic Star, which services the UK dairy and beef sectors.
National Milk Records plc has 21,239,702 issued ordinary shares of which 26.57% are in public hands (Being those shares not held by related parties or by persons who have an interest in 5% or more).
Major interests in Shares
On 14th December 2021 the following shareholders held an interest of 5% or more in the issued share capital of the company.
% of issued
Aurora Nominees Ltd
Livestock Improvement Corporation (UK) Ltd
|PH Nominees Limited|
ROY Nominees Limited
Share options are outstanding over 300,000 ordinary shares of the company. Full exercise of all the options would result in a dilution of 1.4%
No other person has notified an interest in the ordinary shares of the company required to be disclosed in accordance with the Companies Act 2006.